Myocardial Viability and Revascularization

Heart Failure Clinics

Volumn 5, Issue 3, 2009, Pages 333-348

  Kanderian, Anne S ^a   Renapurkar, Rahul ^a   Flamm, Scott D ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Ischemia; MRI; Myocardium; Revascularization; Viability

Indexed keywords

CONTRAST MEDIUM; DOBUTAMINE; FLUORODEOXYGLUCOSE F 18; GADOLINIUM CHELATE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; TETROFOSMIN TC 99M;

CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DRUG TISSUE LEVEL; DRUG UPTAKE; FUNCTIONAL ASSESSMENT; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE; HEART MUSCLE INJURY; HEART MUSCLE REVASCULARIZATION; HEART VENTRICLE WALL; HUMAN; IMAGE ENHANCEMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRESS ECHOCARDIOGRAPHY; THICKNESS;

ADRENERGIC BETA-AGONISTS; ANIMALS; DOBUTAMINE; HUMANS; MAGNETIC RESONANCE IMAGING; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; MYOCARDIUM; TISSUE SURVIVAL;

EID: 67649218564     PISSN: 15517136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hfc.2009.02.008     Document Type: Review

References (62)

1. Shan K., Constantine G., Sivananthan M., et al. Role of cardiac magnetic resonance imaging in the assessment of myocardial viability. Circulation 109 11 (2004) 1328-1334
2. Wagner A., Mahrholdt H., Kim R.J., et al. Use of cardiac magnetic resonance to assess viability. Curr Cardiol Rep 7 1 (2005) 59-64
3. Braunwald E., and Kloner R.A. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation 66 6 (1982) 1146-1149
4. Tillisch J., Brunken R., Marshall R., et al. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med 314 14 (1986) 884-888
5. Dilsizian V., Perrone-Filardi P., Arrighi J.A., et al. Concordance and discordance between stress-redistribution-reinjection and rest-redistribution thallium imaging for assessing viable myocardium. Comparison with metabolic activity by positron emission tomography. Circulation 88 3 (1993) 941-952
6. Meluzin J., Cerny J., Frelich M., et al. Prognostic value of the amount of dysfunctional but viable myocardium in revascularized patients with coronary artery disease and left ventricular dysfunction. Investigators of this multicenter study. J Am Coll Cardiol 32 4 (1998) 912-920
7. Di Carli M.F., Davidson M., Little R., et al. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol 73 8 (1994) 527-533
8. Pagley P.R., Beller G.A., Watson D.D., et al. Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability. Circulation 96 3 (1997) 793-800
9. Beanlands R.S., Ruddy T.D., deKemp R.A., et al. Positron emission tomography and recovery following revascularization (PARR-1): the importance of scar and the development of a prediction rule for the degree of recovery of left ventricular function. J Am Coll Cardiol 40 10 (2002) 1735-1743
10. Nagueh S.F., Mikati I., Weilbaecher D., et al. Relation of the contractile reserve of hibernating myocardium to myocardial structure in humans. Circulation 100 5 (1999) 490-496
11. Eitzman D., al-Aouar Z., Kanter H.L., et al. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. J Am Coll Cardiol 20 3 (1992) 559-565
12. Tamaki N., Kawamoto M., Takahashi N., et al. Prognostic value of an increase in fluorine-18 deoxyglucose uptake in patients with myocardial infarction: comparison with stress thallium imaging. J Am Coll Cardiol 22 6 (1993) 1621-1627
13. Bax J.J., Poldermans D., Elhendy A., et al. Sensitivity, specificity, and predictive accuracies of various noninvasive techniques for detecting hibernating myocardium. Curr Probl Cardiol 26 2 (2001) 147-186
14. Di Carli M.F., Asgarzadie F., Schelbert H.R., et al. Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. Circulation 92 12 (1995) 3436-3444
15. Marwick T.H., Zuchowski C., Lauer M.S., et al. Functional status and quality of life in patients with heart failure undergoing coronary bypass surgery after assessment of myocardial viability. J Am Coll Cardiol 33 3 (1999) 750-758
16. Allman K.C., Shaw L.J., Hachamovitch R., et al. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 39 7 (2002) 1151-1158
17. Shan K., Nagueh S.F., and Zoghbi W.A. Assessment of myocardial viability with stress echocardiography. Cardiol Clin 17 3 (1999) 539-553
18. Cornel J.H., Bax J.J., Elhendy A., et al. Biphasic response to dobutamine predicts improvement of global left ventricular function after surgical revascularization in patients with stable coronary artery disease: implications of time course of recovery on diagnostic accuracy. J Am Coll Cardiol 31 5 (1998) 1002-1010
19. Afridi I., Kleiman N.S., Raizner A.E., et al. Dobutamine echocardiography in myocardial hibernation. Optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. Circulation 91 3 (1995) 663-670
20. Sawada S.G., Lewis S.J., Foltz J., et al. Usefulness of rest and low-dose dobutamine wall motion scores in predicting survival and benefit from revascularization in patients with ischemic cardiomyopathy. Am J Cardiol 89 7 (2002) 811-816
21. Udelson J.E., Coleman P.S., Metherall J., et al. Predicting recovery of severe regional ventricular dysfunction. Comparison of resting scintigraphy with 201Tl and 99mTc-sestamibi. Circulation 89 6 (1994) 2552-2561
22. Marzullo P., Parodi O., Reisenhofer B., et al. Value of rest thallium-201/technetium-99m sestamibi scans and dobutamine echocardiography for detecting myocardial viability. Am J Cardiol 71 2 (1993) 166-172
23. Hoffmann U., Millea R., Enzweiler C., et al. Acute myocardial infarction: contrast-enhanced multi-detector row CT in a porcine model. Radiology 231 3 (2004) 697-701
24. Lardo A.C., Cordeiro M.A., Silva C., et al. Contrast-enhanced multidetector computed tomography viability imaging after myocardial infarction: characterization of myocyte death, microvascular obstruction, and chronic scar. Circulation 113 3 (2006) 394-404
25. Paul J.F., Wartski M., Caussin C., et al. Late defect on delayed contrast-enhanced multi-detector row CT scans in the prediction of SPECT infarct size after reperfused acute myocardial infarction: initial experience. Radiology 236 2 (2005) 485-489
26. Baer F.M., Theissen P., Schneider C.A., et al. Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization. J Am Coll Cardiol 31 5 (1998) 1040-1048
27. Baer F.M., Voth E., Deutsch H.J., et al. Predictive value of low dose dobutamine transesophageal echocardiography and fluorine-18 fluorodeoxyglucose positron emission tomography for recovery of regional left ventricular function after successful revascularization. J Am Coll Cardiol 28 1 (1996) 60-69
28. Nagel E., Lehmkuhl H.B., Bocksch W., et al. Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. Circulation 99 6 (1999) 763-770
29. Sandstede J.J., Bertsch G., Beer M., et al. Detection of myocardial viability by low-dose dobutamine cine MR imaging. Magn Reson Imaging 17 10 (1999) 1437-1443
30. Wesbey G., Higgins C.B., Lanzer P., et al. Imaging and characterization of acute myocardial infarction in vivo by gated nuclear magnetic resonance. Circulation 69 1 (1984) 125-130
31. Kim R.J., Fieno D.S., Parrish T.B., et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 100 19 (1999) 1992-2002
32. Simonetti O.P., Kim R.J., Fieno D.S., et al. An improved MR imaging technique for the visualization of myocardial infarction. Radiology 218 1 (2001) 215-223
33. Weinmann H.J., Laniado M., and Mutzel W. Pharmacokinetics of GdDTPA/dimeglumine after intravenous injection into healthy volunteers. Physiol Chem Phys Med NMR 16 2 (1984) 167-172
34. Kim R.J., Chen E.L., Lima J.A., et al. Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. Circulation 94 12 (1996) 3318-3326
35. Lima J.A., Judd R.M., Bazille A., et al. Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI. Potential mechanisms. Circulation 92 5 (1995) 1117-1125
36. Arheden H., Saeed M., Higgins C.B., et al. Reperfused rat myocardium subjected to various durations of ischemia: estimation of the distribution volume of contrast material with echo-planar MR imaging. Radiology 215 2 (2000) 520-528
37. Flacke S.J., Fischer S.E., and Lorenz C.H. Measurement of the gadopentetate dimeglumine partition coefficient in human myocardium in vivo: normal distribution and elevation in acute and chronic infarction. Radiology 218 3 (2001) 703-710
38. Judd R.M., Lugo-Olivieri C.H., Arai M., et al. Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts. Circulation 92 7 (1995) 1902-1910
39. Klein C., Nekolla S.G., Balbach T., et al. The influence of myocardial blood flow and volume of distribution on late Gd-DTPA kinetics in ischemic heart failure. J Magn Reson Imaging 20 4 (2004) 588-593
40. Klein C., Schmal T.R., Nekolla S.G., et al. Mechanism of late gadolinium enhancement in patients with acute myocardial infarction. J Cardiovasc Magn Reson 9 4 (2007) 653-658
41. Rehwald W.G., Fieno D.S., Chen E.L., et al. Myocardial magnetic resonance imaging contrast agent concentrations after reversible and irreversible ischemic injury. Circulation 105 2 (2002) 224-229
42. Kellman P., Arai A.E., McVeigh E.R., et al. Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement. Magn Reson Med 47 2 (2002) 372-383
43. Kellman P., Larson A.C., Hsu L.Y., et al. Motion-corrected free-breathing delayed enhancement imaging of myocardial infarction. Magn Reson Med 53 1 (2005) 194-200
44. Fieno D.S., Kim R.J., Chen E.L., et al. Contrast-enhanced magnetic resonance imaging of myocardium at risk: distinction between reversible and irreversible injury throughout infarct healing. J Am Coll Cardiol 36 6 (2000) 1985-1991
45. Saeed M., Lund G., Wendland M.F., et al. Magnetic resonance characterization of the peri-infarction zone of reperfused myocardial infarction with necrosis-specific and extracellular nonspecific contrast media. Circulation 103 6 (2001) 871-876
46. Hillenbrand H.B., Kim R.J., Parker M.A., et al. Early assessment of myocardial salvage by contrast-enhanced magnetic resonance imaging. Circulation 102 14 (2000) 1678-1683
47. Gerber B.L., Rochitte C.E., Bluemke D.A., et al. Relation between Gd-DTPA contrast enhancement and regional inotropic response in the periphery and center of myocardial infarction. Circulation 104 9 (2001) 998-1004
48. Choi K.M., Kim R.J., Gubernikoff G., et al. Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function. Circulation 104 10 (2001) 1101-1107
49. Ingkanisorn W.P., Rhoads K.L., Aletras A.H., et al. Gadolinium delayed enhancement cardiovascular magnetic resonance correlates with clinical measures of myocardial infarction. J Am Coll Cardiol 43 12 (2004) 2253-2259
50. Wu E., Judd R.M., Vargas J.D., et al. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet 357 9249 (2001) 21-28
51. Wagner A., Mahrholdt H., Holly T.A., et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet 361 9355 (2003) 374-379
52. Ibrahim T., Bulow H.P., Hackl T., et al. Diagnostic value of contrast-enhanced magnetic resonance imaging and single-photon emission computed tomography for detection of myocardial necrosis early after acute myocardial infarction. J Am Coll Cardiol 49 2 (2007) 208-216
53. Ramani K., Judd R.M., Holly T.A., et al. Contrast magnetic resonance imaging in the assessment of myocardial viability in patients with stable coronary artery disease and left ventricular dysfunction. Circulation 98 24 (1998) 2687-2694
54. Nelson C., McCrohon J., Khafagi F., et al. Impact of scar thickness on the assessment of viability using dobutamine echocardiography and thallium single-photon emission computed tomography: a comparison with contrast-enhanced magnetic resonance imaging. J Am Coll Cardiol 43 7 (2004) 1248-1256
55. Baer F.M., Theissen P., Crnac J., et al. Head to head comparison of dobutamine-transoesophageal echocardiography and dobutamine-magnetic resonance imaging for the prediction of left ventricular functional recovery in patients with chronic coronary artery disease. Eur Heart J 21 12 (2000) 981-991
56. Klein C., Nekolla S.G., Bengel F.M., et al. Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography. Circulation 105 2 (2002) 162-167
57. Kuhl H.P., Beek A.M., van der Weerdt A.P., et al. Myocardial viability in chronic ischemic heart disease: comparison of contrast-enhanced magnetic resonance imaging with (18)F-fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol 41 8 (2003) 1341-1348
58. Knuesel P.R., Nanz D., Wyss C., et al. Characterization of dysfunctional myocardium by positron emission tomography and magnetic resonance: relation to functional outcome after revascularization. Circulation 108 9 (2003) 1095-1100
59. Kim R.J., Wu E., Rafael A., et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 343 20 (2000) 1445-1453
60. Schvartzman P.R., Srichai M.B., Grimm R.A., et al. Nonstress delayed-enhancement magnetic resonance imaging of the myocardium predicts improvement of function after revascularization for chronic ischemic heart disease with left ventricular dysfunction. Am Heart J 146 3 (2003) 535-541
61. Selvanayagam J.B., Kardos A., Francis J.M., et al. Value of delayed-enhancement cardiovascular magnetic resonance imaging in predicting myocardial viability after surgical revascularization. Circulation 110 12 (2004) 1535-1541
62. Lenge V.V., Van den Bosch H., Greenwood J., et al. Delayed-enhancement MRI can predict recovery of LV function after revascularization: results from an international multicenter myocardial viability trial. J Cardiovasc Magn Reson 10 Suppl 1 (2008) A25